Monday, August 07, 2006

Teva Pharmaceutical Industries Receives FDA Approval for Generic Version of Wyeth's Effexor

Generic drug maker Teva Pharmaceutical Industries Ltd. said the U.S. Food and Drug Administration approved its version of Wyeth's depression drug, Effexor.

Israel-based Teva said shipment of the generic version of Venlafaxine Hydrochloride tablets, in several dose ranges, will begin immediately. The ranges include 25-milligram tablets, 37.5-milligram tablets, 75-milligram-tablets and 100-milligram tablets.

Effexor has annual sales of about $152 million, Teva said.

Shares of Teva rose 9 cents to $34.40 on the Nasdaq in Monday morning trading.

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home